Enduring Present Approaches to Testing: Advancing Immunosuppressive Therapy in Solid Organ Transplantation

Course overview

This webinar will explore the critical role of pharmacogenomics and therapeutic drug monitoring (TDM) in managing immunosuppressive therapy for solid organ transplant recipients. With a focus on enhancing patient outcomes and minimizing adverse drug events, our expert presenters will discuss innovative approaches and practical bedside applications. This discussion will be grounded in real-world case examples to highlight the importance of personalized medicine in the complex management of transplant recipients. Objectives: 1. Explain the significance of pharmacogenomics and therapeutic drug monitoring (TDM) in optimizing immunosuppressive therapy for non-liver transplant recipients. 2. Discuss common pharmacogenomic variants affecting key immunosuppressive drugs (e.g., tacrolimus, azathioprine). 3. Apply a structured approach to patient care that integrates pharmacokinetics, pharmacodynamics, and pharmacogenomic data in the management of drug-drug, drug-gene, and drug-drug-gene interactions in transplant patients.